Literature DB >> 30403889

How do you choose the appropriate migraine pharmacotherapy for an elderly person?

Martina Curto1,2, Matilde Capi3, Paolo Martelletti4, Luana Lionetto3.   

Abstract

Entities:  

Keywords:  Aging; elderly; migraine; pharmacotherapy; treatment

Year:  2018        PMID： 30403889     DOI： 10.1080/14656566.2018.1543660

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  2 in total

1.  Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.

Authors:  Stephanie J Nahas; Steffen Naegel; Joshua M Cohen; Xiaoping Ning; Lindsay Janka; Verena Ramirez Campos; Lynda J Krasenbaum; Dagny Holle-Lee; David Kudrow; Christian Lampl
Journal:  J Headache Pain       Date:  2021-11-24       Impact factor: 7.277

2.  Eptinezumab for migraine prevention in patients 50 years or older.

Authors:  Vincent Martin; Cristina Tassorelli; Anders Ettrup; Joe Hirman; Roger Cady
Journal:  Acta Neurol Scand       Date:  2022-02-26       Impact factor: 3.915
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.